Abstract 507: Repurposing of FDA approved drugs for treatment of metastatic HNSCC (Q116047027)
Jump to navigation
Jump to search
scientific article published in 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Abstract 507: Repurposing of FDA approved drugs for treatment of metastatic HNSCC |
scientific article published in 2020 |
Statements
Abstract 507: Repurposing of FDA approved drugs for treatment of metastatic HNSCC (English)
Maria Kondratyev
Aleksandra Pesic
Anna Dvorkin-Sheva
Troy Ketela
Jason Moffat
Marianne Koritzinsky
Brad Wouters
15 August 2020
16_Supplement
507-507